Elanco Animal Health (ELAN) reported $4.7B in revenue for fiscal 2025, +6.2% year on year. That ranks #845 by revenue among 2853 SEC filers and #74 in Healthcare. It posted a net loss of −$232M for the same year. Revenue has grown 5.5% a year on average since 2016 ($2.9B then). The fiscal 2025 balance sheet shows $13.4B in total assets, $545M in cash and $3.8B in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $4.7B | +6.2% | FY20252025-12-31 |
| Gross profitGrossProfit | $2.6B | +6.4% | FY20252025-12-31 |
| Operating incomeIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | −$224M | −$712M | FY20252025-12-31 |
| Net incomeNetIncomeLoss | −$232M | −$570M | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $560M | +3.5% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $276M | +87.8% | FY20252025-12-31 |
| Total assetsAssets | $13.4B | +5.9% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $6.5B | +7.4% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $545M | +16.5% | FY20252025-12-31 |
| Long-term debtLongTermDebt | $3.8B | −12.0% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $1.4B | $57.0M | Open → |
| Q2 20262026-06-30 | $1.4B | $54.0M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 133 of 161 companies compared | −4.9% | |
| Operating marginRank 139 of 160 companies compared | −4.8% | |
| R&D as share of revenueRank 53 of 102 companies compared | 7.8% | |
| Cash as share of revenueRank 77 of 160 companies compared | 11.6% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Elanco Animal Health Inc
- Ticker
- ELAN
- Exchange
- NYSE
- SIC classification
- Pharmaceutical Preparations (2834)
- Fiscal year end
- 12-31
- CIK
- 0001739104
Filings
- 10-QAug 5, 2026Open filing →
- 10-QMay 6, 2026Open filing →
- 10-KFeb 24, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Bausch & LombBLCO | $5.1B | −$360M |
| Ensign GroupENSG | $5.1B | $344M |
| HerbalifeHLF | $5.0B | $228M |
| Elanco Animal HealthELAN | $4.7B | −$232M |
| DexcomDXCM | $4.7B | $836M |
| Cno FinancialCNO | $4.5B | $229M |
| Idexx LaboratoriesIDXX | $4.3B | $1.1B |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Elanco Animal Health — Key figures |url=https://companiesranked.com/en/company/elanco-animal-health |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Elanco Animal Health — Key figures. CompaniesRanked. https://companiesranked.com/en/company/elanco-animal-healthBibTeX
@misc{companiesranked-en-company-elanco-animal-health-2026,
author = {{CompaniesRanked}},
title = {{Elanco Animal Health — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/elanco-animal-health}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001739104-26-000012 · February 24, 2026
{{cite web |title=Elanco Animal Health — Key figures — 10-K (0001739104-26-000012) |url=https://www.sec.gov/Archives/edgar/data/1739104/000173910426000012/elan-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.